tiprankstipranks
Advertisement
Advertisement
Revvity reports Q2 adjusted EPS $1.41, consensus $1.22
PremiumThe FlyRevvity reports Q2 adjusted EPS $1.41, consensus $1.22
13d ago
Revvity enters definitive agreement to divest China Immunodiagnostics business
Premium
The Fly
Revvity enters definitive agreement to divest China Immunodiagnostics business
13d ago
Revvity raises FY26 adjusted EPS view to $5.30-$5.40 from $5.20-$5.30
Premium
The Fly
Revvity raises FY26 adjusted EPS view to $5.30-$5.40 from $5.20-$5.30
13d ago
Revvity Signals Software business joined Anthropic’s directory
PremiumThe FlyRevvity Signals Software business joined Anthropic’s directory
2M ago
Revvity resumed with a Market Perform at Bernstein
Premium
The Fly
Revvity resumed with a Market Perform at Bernstein
2M ago
Early notable gainers among liquid option names on June 25th
Premium
The Fly
Early notable gainers among liquid option names on June 25th
2M ago
Revvity price target lowered to $117 from $125 at Baird
PremiumThe FlyRevvity price target lowered to $117 from $125 at Baird
3M ago
Revvity price target lowered to $100 from $110 at Stifel
Premium
The Fly
Revvity price target lowered to $100 from $110 at Stifel
3M ago
Revvity price target lowered to $90 from $96 at JPMorgan
Premium
The Fly
Revvity price target lowered to $90 from $96 at JPMorgan
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100